TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Designing a Food Benefit Program to Optimize Diet Quality for Obesity Prevention
Brief Summary: This highly innovative experimental trial is designed to examine the independent and joint effects of prohibiting the use of SNAP-like benefits to purchase foods high in discretionary calories and offering an incentive to encourage the purchase of more healthful foods.


Options:
A: Intervention Type: BEHAVIORAL; Name: diet, sodium-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, fat-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, reducing; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: alcohol drinking; Assigned to Arm(s): N/A
B: Arm Label: dietary intervention 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: lemonade with sugar | Arm Label: dietary intervention 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: lemonade low in sugar | Intervention Type: DIETARY_SUPPLEMENT; Name: lemonade with sugar; Assigned to Arm(s): dietary intervention 1 | Intervention Type: DIETARY_SUPPLEMENT; Name: lemonade low in sugar; Assigned to Arm(s): dietary intervention 2
C: Arm Label: Diet + Water; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counseling | Arm Label: Diet; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dietary counseling | Intervention Type: BEHAVIORAL; Name: Dietary counseling; Assigned to Arm(s): Diet, Diet + Water
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Rewards; Type: EXPERIMENTAL; Interventions: Behavioral: F&V Bonus | Arm Label: Restrictions; Type: EXPERIMENTAL; Interventions: Behavioral: Restriction | Arm Label: Rewards plus restrictions; Type: EXPERIMENTAL; Interventions: Behavioral: Bonus & Restriction | Intervention Type: BEHAVIORAL; Name: F&V Bonus; Assigned to Arm(s): Rewards | Intervention Type: BEHAVIORAL; Name: Restriction; Assigned to Arm(s): Restrictions | Intervention Type: BEHAVIORAL; Name: Bonus & Restriction; Assigned to Arm(s): Rewards plus restrictions

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Influence of Different Types of Exercise Training on Selected Cardiovascular Parameters in Adult Individuals With Corrected Tetralogy of Fallot
Brief Summary: In this controlled trial, patients with tetralogy of Fallot will be randomized to either interval training, continuous training, or usual care groups.


Options:
A: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: One active intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: an mHealth intervention | Arm Label: The other active intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: an mHealth intervention | Intervention Type: BEHAVIORAL; Name: an mHealth intervention; Assigned to Arm(s): One active intervention group, The other active intervention group
B: Arm Label: Interval training group; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise training | Arm Label: Continuous training group; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise training | Arm Label: Usual care group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Exercise training; Assigned to Arm(s): Continuous training group, Interval training group
C: Arm Label: Cardiopulmonary rehabilitation; Type: EXPERIMENTAL; Interventions: Other: Cardiopulmonary rehabilitation | Arm Label: Standard of care; Type: OTHER; Interventions: Other: Standard of care | Intervention Type: OTHER; Name: Cardiopulmonary rehabilitation; Assigned to Arm(s): Cardiopulmonary rehabilitation | Intervention Type: OTHER; Name: Standard of care; Assigned to Arm(s): Standard of care
D: Arm Label: Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Training | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training; Assigned to Arm(s): Training

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Uncut Roux-en-Y Gastrojejunostomy on Quality of Life After Laparoscopic Distal Gastrectomy for Early Gastric Cancer Patients
Brief Summary: The current commonly used for distal gastri cancer in gastrointestinal anastomosis is Roux-en-Y. However, the complications after Roux-en-Y reach an incidence of over 30% which involve nausea, vomiting, and abdominal distension. The underlying mechanism might be the result of interruption of intestine peristalsis. In 2013, Kim reported total laparoscopic uncut Roux-en-Y anastomosis could reduce Roux stasis syndrome incidence by keeping the continuity of jejunum. In September 2014, we carried out this operation in 30 cases in our centre. Our previous results showed that this operation had a low postoperative complication and short hospitalization time, indicating uncut Roux-en-Y anastomosis might be a safe procedure. However, some limitations are noticed. The report from South Korea is a retrospective study and the evaluation of QOL is certain subjective. Here, we aimed to perform the first randomized controlled clinical study on uncut Roux-en-Y anastomosis to improve QOL of patients after laparoscopic distal gastrectomy.


Options:
A: Arm Label: the group of Roux-en-Y; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Roux-en-Y reconstruction | Arm Label: the group of Uncut Roux-en-Y; Type: EXPERIMENTAL; Interventions: Procedure: Uncut Roux-en-Y reconstruction | Intervention Type: PROCEDURE; Name: Uncut Roux-en-Y reconstruction; Assigned to Arm(s): the group of Uncut Roux-en-Y | Intervention Type: PROCEDURE; Name: Roux-en-Y reconstruction; Assigned to Arm(s): the group of Roux-en-Y
B: Arm Label: Conventional Roux-en-Y anastomosis; Type: OTHER; Interventions: Procedure: Conventional Roux-en-Y Gastrojejunostomy | Arm Label: Uncut Roux-en-Y anastomosis; Type: EXPERIMENTAL; Interventions: Procedure: Uncut Roux-en-Y Gastrojejunostomy | Intervention Type: PROCEDURE; Name: Conventional Roux-en-Y Gastrojejunostomy; Assigned to Arm(s): Conventional Roux-en-Y anastomosis | Intervention Type: PROCEDURE; Name: Uncut Roux-en-Y Gastrojejunostomy; Assigned to Arm(s): Uncut Roux-en-Y anastomosis
C: Arm Label: uncut Roux-en-Y anastomosis; Type: EXPERIMENTAL; Interventions: Procedure: Uncut Roux-en-Y anastomosis | Arm Label: Billroth II anastomosis; Type: SHAM_COMPARATOR; Interventions: Procedure: Billroth II anastomosis | Intervention Type: PROCEDURE; Name: Uncut Roux-en-Y anastomosis; Assigned to Arm(s): uncut Roux-en-Y anastomosis | Intervention Type: PROCEDURE; Name: Billroth II anastomosis; Assigned to Arm(s): Billroth II anastomosis
D: Arm Label: modified BII+Braun; Type: ACTIVE_COMPARATOR; Interventions: Procedure: modified BII+Braun | Arm Label: traditional BII+Braun; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: modified BII+Braun; Assigned to Arm(s): modified BII+Braun

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Technology Assisted Cascade Training and Supervision of Community Health Workers in Delivering Thinking Healthy Program for Perinatal Depression in a Post-conflict Area of Pakistan- Protocol of a Randomized Controlled Trial
Brief Summary: The Thinking Healthy Program is evidence based psychological intervention, delivered by non-specialists, with proven impact on maternal depression. A major challenge in the scale-up of this intervention, especially where health systems are weak, is providing quality training and supervision at scale. Women living in post-conflict areas are at a higher risk of depression than the general population.The key innovation proposed is the development and evaluation of a technology-assisted cascade training and supervision system to assist scale-up of the Thinking Healthy Programme in a post conflict area of Pakistan.


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: PC101+Mental Health | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: PC101+Mental Health | Intervention Type: BEHAVIORAL; Name: PC101+Mental Health; Assigned to Arm(s): Control, Intervention
B: Arm Label: Intervention Program of Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Patient Education and Behavioral Activation, Behavioral: Supporting Self-Care (care coordinators), Other: Psychiatrist and Diabetologist Reviews, Other: Decision-support Electronic Health Record System | Arm Label: Control Arm; Type: PLACEBO_COMPARATOR; Interventions: Other: Standard of Care | Intervention Type: BEHAVIORAL; Name: Patient Education and Behavioral Activation; Assigned to Arm(s): Intervention Program of Care | Intervention Type: BEHAVIORAL; Name: Supporting Self-Care (care coordinators); Assigned to Arm(s): Intervention Program of Care | Intervention Type: OTHER; Name: Psychiatrist and Diabetologist Reviews; Assigned to Arm(s): Intervention Program of Care | Intervention Type: OTHER; Name: Decision-support Electronic Health Record System; Assigned to Arm(s): Intervention Program of Care | Intervention Type: OTHER; Name: Standard of Care; Assigned to Arm(s): Control Arm
C: Arm Label: Technology Arm; Type: EXPERIMENTAL; Interventions: Other: Avatar assisted cascade training | Arm Label: Specialist Arm; Type: ACTIVE_COMPARATOR; Interventions: Other: Specialist led training in THP | Intervention Type: OTHER; Name: Avatar assisted cascade training; Assigned to Arm(s): Technology Arm | Intervention Type: OTHER; Name: Specialist led training in THP; Assigned to Arm(s): Specialist Arm
D: Arm Label: Primary Care 101 Enhanced guideline; Type: EXPERIMENTAL; Interventions: Other: Primary care 101 plus mental health | Arm Label: Standard of care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Primary Care 101 | Intervention Type: OTHER; Name: Primary care 101 plus mental health; Assigned to Arm(s): Primary Care 101 Enhanced guideline | Intervention Type: OTHER; Name: Standard Primary Care 101; Assigned to Arm(s): Standard of care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Pilates Method in Muscle Strength of the Pelvic Floor as Treatment of Post Prostatectomy Urinary Incontinence: : a Randomized Control Trial
Brief Summary: The purpose of this study is to compare the efficacy between a Pilates exercise program and a Pelvic Floor Muscle Training (PFMT) protocol combined with anal electrical stimulation (AES) in muscular pressure strength of the pelvic floor as conservative treatment of urinary incontinence after prostatectomy.


Options:
A: Arm Label: BF+SUPPORT; Type: EXPERIMENTAL; Interventions: Behavioral: BF+SUPPORT | Arm Label: BF+PHONE; Type: EXPERIMENTAL; Interventions: Behavioral: BF+PHONE | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: BF+SUPPORT; Assigned to Arm(s): BF+SUPPORT | Intervention Type: BEHAVIORAL; Name: BF+PHONE; Assigned to Arm(s): BF+PHONE
B: Arm Label: PILATES; Type: EXPERIMENTAL; Interventions: Other: Pilates | Arm Label: PFMT and AES; Type: ACTIVE_COMPARATOR; Interventions: Other: PFMT and AES | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Pilates; Assigned to Arm(s): PILATES | Intervention Type: OTHER; Name: PFMT and AES; Assigned to Arm(s): PFMT and AES | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
C: Arm Label: electrostimulation with exercises MAPs; Type: EXPERIMENTAL; Interventions: Other: electrostimulation with exercises MAPs | Arm Label: exercises MAPs; Type: ACTIVE_COMPARATOR; Interventions: Other: exercises MAPs | Intervention Type: OTHER; Name: electrostimulation with exercises MAPs; Assigned to Arm(s): electrostimulation with exercises MAPs | Intervention Type: OTHER; Name: exercises MAPs; Assigned to Arm(s): exercises MAPs
D: Arm Label: Transcutaneous perineal stimulation; Type: EXPERIMENTAL; Interventions: Other: Transcutaneous perineal stimulation | Arm Label: Anal stimulation; Type: ACTIVE_COMPARATOR; Interventions: Other: Anal stimulation | Intervention Type: OTHER; Name: Transcutaneous perineal stimulation; Assigned to Arm(s): Transcutaneous perineal stimulation | Intervention Type: OTHER; Name: Anal stimulation; Assigned to Arm(s): Anal stimulation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Intravenous Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Proliferative Lupus Nephritis
Brief Summary: This study will be conducted to find out whether low dose or high dose cyclophosphamide therapy is effective in the treatment of proliferative lupus nephritis.It will also compare the side effects and risks of infection in low dose and high dose cyclophosphamide group. Half of the participants will receive a low dose cyclophosphamide for 3 months and half will receive high dose cyclophosphamide therapy monthly for 6 months followed by azathioprine 2 mg/kg.


Options:
A: Intervention Type: DRUG; Name: Abetimus sodium (LJP 394); Assigned to Arm(s): N/A
B: Arm Label: Low dose Cyclophosphamide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cyclophosphamide, Drug: Azathioprine, Drug: Methylprednisolone | Arm Label: High Dose Cyclophosphamide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cyclophosphamide, Drug: Azathioprine, Drug: Methylprednisolone | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): High Dose Cyclophosphamide, Low dose Cyclophosphamide | Intervention Type: DRUG; Name: Azathioprine; Assigned to Arm(s): High Dose Cyclophosphamide, Low dose Cyclophosphamide | Intervention Type: DRUG; Name: Methylprednisolone; Assigned to Arm(s): High Dose Cyclophosphamide, Low dose Cyclophosphamide
C: Arm Label: CNTO 136; Type: EXPERIMENTAL; Interventions: Drug: CNTO 136 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: CNTO 136; Assigned to Arm(s): CNTO 136 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: tacrolimus (FK506) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: cyclophosphamide or azathioprine | Intervention Type: DRUG; Name: tacrolimus (FK506); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: cyclophosphamide or azathioprine; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intervention to Promote Medical Students Empathy, Well-being and Study emotion-a Randomized Clinical Trial.
Brief Summary: The doctor-patient relationship was becoming worse. More and more work-related violence has happened to physicians and nurses. A portion of medical students felt depressed and thought that the career future was gloomy. The study was designed to measure the empathy, an vital element of professionalism, well-being of mental and study emotion. Furthermore, the investigators explored an intervention of group study to promote medical students' professionalism, mental health and study emotion.


Options:
A: Arm Label: Narrative Exposure Therapy (FORNET, adapted version); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: FORNET (adapted version) | Arm Label: Waitlist control or treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: FORNET (adapted version); Assigned to Arm(s): Narrative Exposure Therapy (FORNET, adapted version)
B: Arm Label: intervention group; Type: EXPERIMENTAL; Interventions: Other: Education of medical humanities | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Education of medical humanities; Assigned to Arm(s): intervention group
C: Arm Label: Mothers and Babies Groups Home-Visitor; Type: EXPERIMENTAL; Interventions: Behavioral: Mothers and Babies Groups | Arm Label: Mothers and Babies Groups Clinician; Type: EXPERIMENTAL; Interventions: Behavioral: Mothers and Babies Groups | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mothers and Babies Groups; Assigned to Arm(s): Mothers and Babies Groups Clinician, Mothers and Babies Groups Home-Visitor
D: Arm Label: Intervention KMC; Type: EXPERIMENTAL; Interventions: Behavioral: KMC, Other: Essential newborn care | Arm Label: Control; Type: OTHER; Interventions: Other: Essential newborn care | Intervention Type: BEHAVIORAL; Name: KMC; Assigned to Arm(s): Intervention KMC | Intervention Type: OTHER; Name: Essential newborn care; Assigned to Arm(s): Control, Intervention KMC

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Scleroligation is a Safe and Effective New Technique for Eradication of Gastroesophageal Varices.
Brief Summary: Gastric varices occur in 5-33% of patients with portal hypertension. Concomitant gastro esophageal varices are the most common type. Both endoscopic sclerotherapy and band ligation are very effective in controlling acute esophageal varices bleeding and preventing rebleeding.


Options:
A: Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Drug: Terlipressin | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Octreotide | Intervention Type: DRUG; Name: Terlipressin; Assigned to Arm(s): Experimental group | Intervention Type: DRUG; Name: Octreotide; Assigned to Arm(s): Control group
B: Arm Label: EVL plus Somatostatin; Type: EXPERIMENTAL; Interventions: Drug: Somatostatin | Arm Label: EVL plus Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Somatostatin; Assigned to Arm(s): EVL plus Somatostatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): EVL plus Placebo
C: Arm Label: Sclerotherapy group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Sclerotherapy | Arm Label: Endoscopic band ligation group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Band ligation | Arm Label: Sclero-ligation (SL) group; Type: EXPERIMENTAL; Interventions: Procedure: Scleroligation | Intervention Type: PROCEDURE; Name: Sclerotherapy; Assigned to Arm(s): Sclerotherapy group | Intervention Type: PROCEDURE; Name: Band ligation; Assigned to Arm(s): Endoscopic band ligation group | Intervention Type: PROCEDURE; Name: Scleroligation; Assigned to Arm(s): Sclero-ligation (SL) group
D: Arm Label: Self-expandable esophageal stent; Type: ACTIVE_COMPARATOR; Interventions: Device: Stent | Arm Label: Sengstaken-Blakemore tube; Type: ACTIVE_COMPARATOR; Interventions: Device: Tamponade | Intervention Type: DEVICE; Name: Stent; Assigned to Arm(s): Self-expandable esophageal stent | Intervention Type: DEVICE; Name: Tamponade; Assigned to Arm(s): Sengstaken-Blakemore tube

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Efficacy and Safety Between Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension: a Randomized Controlled Trial
Brief Summary: The purpose of this study is to compare the effect of fosinopril plus benidipine vs. fosinopril plus hydrochlorothiazide on the renal function during the 6-month treatment in CKD patients with HTN.


Options:
A: Intervention Type: DRUG; Name: Inhibitors, ACE; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: amlodipine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: lisinopril; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: doxazosin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: chlorthalidone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: pravastatin; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, fat-restricted; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Valsartan + amlodipine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Valsartan + HCTZ; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Amlodipine + HCTZ; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Valsartan + amlodipine + HCTZ; Assigned to Arm(s): N/A
C: Arm Label: OM40/AML10; Type: EXPERIMENTAL; Interventions: Drug: Olmesartan medoxomil, Drug: Amlodipine | Arm Label: OM40/HCTZ25; Type: ACTIVE_COMPARATOR; Interventions: Drug: Olmesartan medoxomil, Drug: Hydrochlorothiazide | Arm Label: AML10/HCTZ25; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amlodipine, Drug: Hydrochlorothiazide | Arm Label: OM40/AML10/HCTZ25; Type: ACTIVE_COMPARATOR; Interventions: Drug: Olmesartan medoxomil, Drug: Amlodipine, Drug: Hydrochlorothiazide | Intervention Type: DRUG; Name: Olmesartan medoxomil; Assigned to Arm(s): OM40/AML10, OM40/AML10/HCTZ25, OM40/HCTZ25 | Intervention Type: DRUG; Name: Amlodipine; Assigned to Arm(s): AML10/HCTZ25, OM40/AML10, OM40/AML10/HCTZ25 | Intervention Type: DRUG; Name: Hydrochlorothiazide; Assigned to Arm(s): AML10/HCTZ25, OM40/AML10/HCTZ25, OM40/HCTZ25
D: Arm Label: Fosinopril,benidipine combination; Type: EXPERIMENTAL; Interventions: Drug: Fosinopril, Drug: Benidipine | Arm Label: Fosinopril,hydrochlorothiazide combination; Type: EXPERIMENTAL; Interventions: Drug: Fosinopril, Drug: Hydrochlorothiazide | Intervention Type: DRUG; Name: Fosinopril; Assigned to Arm(s): Fosinopril,benidipine combination, Fosinopril,hydrochlorothiazide combination | Intervention Type: DRUG; Name: Benidipine; Assigned to Arm(s): Fosinopril,benidipine combination | Intervention Type: DRUG; Name: Hydrochlorothiazide; Assigned to Arm(s): Fosinopril,hydrochlorothiazide combination

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Efficacy and Safety Between Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension: a Randomized Controlled Trial
Brief Summary: The purpose of this study is to compare the effect of fosinopril plus benidipine vs. fosinopril plus hydrochlorothiazide on the renal function during the 6-month treatment in CKD patients with HTN.


Options:
A: Arm Label: Valsartan; Type: ACTIVE_COMPARATOR; Interventions: Drug: Valsartan | Arm Label: Amlodipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amlodipine | Intervention Type: DRUG; Name: Valsartan; Assigned to Arm(s): Valsartan | Intervention Type: DRUG; Name: Amlodipine; Assigned to Arm(s): Amlodipine
B: Arm Label: Fosinopril,benidipine combination; Type: EXPERIMENTAL; Interventions: Drug: Fosinopril, Drug: Benidipine | Arm Label: Fosinopril,hydrochlorothiazide combination; Type: EXPERIMENTAL; Interventions: Drug: Fosinopril, Drug: Hydrochlorothiazide | Intervention Type: DRUG; Name: Fosinopril; Assigned to Arm(s): Fosinopril,benidipine combination, Fosinopril,hydrochlorothiazide combination | Intervention Type: DRUG; Name: Benidipine; Assigned to Arm(s): Fosinopril,benidipine combination | Intervention Type: DRUG; Name: Hydrochlorothiazide; Assigned to Arm(s): Fosinopril,hydrochlorothiazide combination
C: Intervention Type: DRUG; Name: Delapril, Delapril-Manidipine Fixed combination; Assigned to Arm(s): N/A
D: Arm Label: OM40/AML10; Type: EXPERIMENTAL; Interventions: Drug: Olmesartan medoxomil, Drug: Amlodipine | Arm Label: OM40/HCTZ25; Type: ACTIVE_COMPARATOR; Interventions: Drug: Olmesartan medoxomil, Drug: Hydrochlorothiazide | Arm Label: AML10/HCTZ25; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amlodipine, Drug: Hydrochlorothiazide | Arm Label: OM40/AML10/HCTZ25; Type: ACTIVE_COMPARATOR; Interventions: Drug: Olmesartan medoxomil, Drug: Amlodipine, Drug: Hydrochlorothiazide | Intervention Type: DRUG; Name: Olmesartan medoxomil; Assigned to Arm(s): OM40/AML10, OM40/AML10/HCTZ25, OM40/HCTZ25 | Intervention Type: DRUG; Name: Amlodipine; Assigned to Arm(s): AML10/HCTZ25, OM40/AML10, OM40/AML10/HCTZ25 | Intervention Type: DRUG; Name: Hydrochlorothiazide; Assigned to Arm(s): AML10/HCTZ25, OM40/AML10/HCTZ25, OM40/HCTZ25

Answer: B